Impact of other pretransplant characteristics
There were significant differences in the negative conversion rate of HBsAb after transplantation between patients treated with and without ATG (P=0.047), patients treated with and without corticosteroids (P=0.009), and patients with and without GVHD (P<0.001). However, there was no difference in the negative conversion rate of HBsAb based on pretransplant characteristics, including patient age, sex and human leukocyte antigen (HLA) compatibility (P >0.05) (Table 2).